← Leaderboards
Yakeel T. Quiroz
Massachusetts General Hospital
$18,816,029
Attributed
$38,399,554
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $18M · FY2011–25$20M$15M$10M$5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,399,554 · 9
By mechanism
R01$28,977,100 · 4
RM1$3,821,618 · 1
DP5$2,279,184 · 1
RF1$1,969,396 · 1
U01$1,325,724 · 1
F31$26,532 · 1
Top collaborators
- David Fernando Aguillon5 shared
- A Claudio Cuello4 shared
- Robert C Alexander3 shared
- Jessica Brooke Langbaum3 shared
- Eric M Reiman3 shared
- Joseph Arboleda-Velasquez1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Laura Maria Calvi$9,706,127
- Sava Sakadzic$6,785,772
- Cenk Ayata$15,872,648
- Bernard Khor$4,267,406
- Edmarie Guzmãn-Vãlez$881,247
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainCognitivePre-ClinicalAmyloidBiological MarkersImpaired CognitionDementiaTau ProteinsCognitive PerformanceMutation CarrierMemoryFunctional Magnetic Resonance ImagingPositron-Emission TomographyMutationEarly DiagnosisPresenilin-1CognitionImageKindredPathologyAmyloid PathologyMagnetic Resonance Imaging
Grant awards (28)
Alzheimer's Prevention Initiative ADAD Colombia Trial Program$15,521,010
R01 · FY2025 · AG
Boston Latino Aging Study (BLAST): Understanding Alzheimer's risk and biomarkers in older Latinos$822,778
R01 · FY2025 · AG · contact PI
Alzheimer's Prevention Initiative ADAD Colombia Trial Program$344,001
R01 · FY2025 · AG
Examining sex-differences in puberty and brain development in carriers of autosomal dominant Alzheimer's disease$343,092
U01 · FY2025 · AG · contact PI
Examining sex-differences in puberty and brain development in carriers of autosomal dominant Alzheimer's disease$303,549
U01 · FY2025 · AG · contact PI
Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's disease$284,072
R01 · FY2025 · AG · contact PI
Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's disease$195,927
R01 · FY2025 · AG · contact PI
Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's disease$147,065
R01 · FY2025 · AG · contact PI
Alzheimer's Prevention Initiative ADAD Colombia Trial Program$4,541,398
R01 · FY2024 · AG
Boston Latino Aging Study (BLAST): Understanding Alzheimer's risk and biomarkers in older Latinos$839,568
R01 · FY2024 · AG · contact PI
Examining sex-differences in puberty and brain development in carriers of autosomal dominant Alzheimer's disease$679,083
U01 · FY2024 · AG · contact PI
Resilience to Cognitive Decline and Resistance to Alzheimer's Disease and Related Neurodegenerative Diseases in Individuals from Colombia with Autosomal Dominant Dementias$3,821,618
RM1 · FY2023 · NS · contact PI
Boston Latino Aging Study (BLAST): Understanding Alzheimer's risk and biomarkers in older Latinos$839,568
R01 · FY2023 · AG · contact PI
Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's disease$1,969,396
RF1 · FY2022 · AG · contact PI
Boston Latino Aging Study (BLAST): Understanding Alzheimer's risk and biomarkers in older Latinos$839,568
R01 · FY2022 · AG · contact PI
Boston Latino Aging Study (BLAST): Understanding Alzheimer's risk and biomarkers in older Latinos$839,568
R01 · FY2021 · AG · contact PI
Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's disease$745,104
R01 · FY2021 · AG · contact PI
Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's disease$745,104
R01 · FY2020 · AG · contact PI
Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's disease$745,104
R01 · FY2019 · AG · contact PI
Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's disease$745,104
R01 · FY2018 · AG · contact PI
Memory network dysfunction as an early marker of preclinical Alzheimer's Disease$408,600
DP5 · FY2018 · OD · contact PI
Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's disease$782,161
R01 · FY2017 · AG · contact PI
Memory network dysfunction as an early marker of preclinical Alzheimer's Disease$517,442
DP5 · FY2017 · OD · contact PI
Memory network dysfunction as an early marker of preclinical Alzheimer's Disease$408,600
DP5 · FY2016 · OD · contact PI
Memory network dysfunction as an early marker of preclinical Alzheimer's Disease$108,842
DP5 · FY2016 · OD · contact PI
Memory network dysfunction as an early marker of preclinical Alzheimer's Disease$408,600
DP5 · FY2015 · OD · contact PI
Memory network dysfunction as an early marker of preclinical Alzheimer's Disease$427,100
DP5 · FY2014 · OD · contact PI
Structural and Functional Neuroanatomy of Memory in Familial Alzheimer's Disease$26,532
F31 · FY2011 · NS · contact PI